IMI project provides world’s first preclinical drug tests for children with cancer
IMI project ITCC-P4 addresses the urgent need for better tools to study childhood cancers.
IHI project GUIDE.MRD banks on better blood tests to detect cancer
Following surgery to remove a tumour, blood tests could help to identify which patients really need further treatment, and which don’t.
Apply now to calls 4 & 5
Have you applied yet for calls 4 and 5? You've still got time - the deadline for call 4 is 8 November 2023 while for call 5 it's 16 January 2024. The topics covered in call 4 and 5 contribute to key EU policies such as the European Green Deal and the '3Rs' goals of replacing, reducing and refining the use of animals in research.
Read more
IHI project IMAGIO targets more precise cancer treatments, with limited side effects
IMAGIO focuses on ‘interventional oncology’, which uses miniaturised instruments to target cancer cells more precisely, thereby sparing healthy cells from the toxic effects of many treatments.
Revealing an earlier and more effective way to diagnose Alzheimer’s disease
Research by IMI project AMYPAD reveals that carrying out a PET scan of the brain can result in a faster, more certain diagnosis for patients with suspected Alzheimer’s disease.
Catch up on the Call Days webinars!
Re-watch the info sessions for calls 4 and 5 to learn more about the topics and what we're looking for in a proposal.
Watch the webinars
In conversation with... iConsensus
In conversation with… iConsensus is an online event that discusses how to make a more efficient, cost-effective and user-friendly process for the development and manufacture of biopharmaceuticals, focusing on the IMI iConsensus project.
IHI contributing partners – who, why and how?
This webinar will explore the who, what, why and how of becoming an IHI contributing partner. As the name suggests, contributing partners invest their own resources in a specific IHI project or projects, and they are not members of IHI's industry partners.